Tramadol was approved by the U.S. Food and Drug Administration in March 1995 as a noncontrolled substance but was reclassified in 2014 as a schedule IV medication under the Controlled Substances Act ...

Objective: To assess the efficacy, safety and impact on quality of life of tramadol in the treatment of neuropathic pain in patients with cancer. Methods: Patients with similar characteristics were ...

Tramadol, a commonly prescribed opioid often viewed as a safer option for chronic pain, provided limited pain relief while increasing the risk for serious side effects, results of a new analysis ...

Tramadol reduced chronic pain but the effect was below a predefined threshold, data from 19 trials suggested. Serious adverse events were higher with tramadol versus placebo. Most trials had a high ...

After Tylenol, a popular pain medicine in the US was in debate of whether it causes autism, the debate has now shifted to Tramadol. It is an opioid pain medicine used to treat moderate to moderately ...

Talk about a dose of disappointment. A new analysis suggests that millions of Americans with chronic pain are being prescribed an opioid that does little to ease their suffering. To make matters worse ...